• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与同龄人相比,患有镰状细胞病的儿童和年轻人的脑动脉管腔会扩大。

Cerebral arterial lumens are enlarged in children and young adults with sickle cell disease compared to peers.

作者信息

Lewis Josiah B, Fields Melanie E, Binkley Michael M, Zhou Anita, Mirro Amy, Ouyang Amy, Gupta Niket, Chen Yasheng, Fellah Slim, Smith Alyssa E, Dedkov Igor, Hulbert Monica L, Ford Andria L, An Hongyu, Lee Jin-Moo, Goyal Manu S, Guilliams Kristin P

机构信息

Department of Neurology, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO, 63110, USA.

Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO, 63110, USA.

出版信息

Neuroimage Rep. 2025 Jun;5(2). doi: 10.1016/j.ynirp.2025.100265. Epub 2025 May 9.

DOI:10.1016/j.ynirp.2025.100265
PMID:40535957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12172934/
Abstract

Children with sickle cell disease (SCD) may develop large vessel narrowing, but studies suggest vessels may also be enlarged, possibly related to increased cerebral blood flow (CBF). We used MRI to investigate whether the cross-sectional total inflow vessel luminal area (TIVLA) proximal to the circle of Willis (carotid arteries + basilar artery) would be increased in SCD compared to age- and sex-matched peers after adjusting for CBF. Across 36 children with SCD (19 female, median age 10.7 [8.0-14.5] years and 43 controls (26 female, median age 12.7 [9.2-18.2] years) matched by age ( = 0.13) and sex ( = 0.50), the median TIVLA in the SCD group (35.9 mm [30.7, 39.5]) was larger than controls (30.5 mm [27.8, 35.4], = 0.002). In a mixed model including age, sex, hemoglobin, CBF, SCD status, and an interaction between hemoglobin and SCD status, CBF (β = 0.11, CI 0.02-0.20, = 0.02), SCD (β = 28.02, CI 5.62-50.42, = 0.015), and the interaction between SCD and hemoglobin (β = -2.48, CI -4.49 to -0.47, = 0.018) were all significantly associated with increased TIVLA. Notably, TIVLA as a measure of arterial lumens is larger in children with SCD, even after adjusting for CBF in the mixed model. This implies disease-specific normative values may be needed to detect early vasculopathy.

摘要

患有镰状细胞病(SCD)的儿童可能会出现大血管狭窄,但研究表明血管也可能会扩张,这可能与脑血流量(CBF)增加有关。我们使用磁共振成像(MRI)来研究,在调整脑血流量后,与年龄和性别匹配的同龄人相比,患有SCD的儿童 Willis 环近端(颈动脉+基底动脉)的横断面总流入血管腔面积(TIVLA)是否会增加。在36名患有SCD的儿童(19名女性,中位年龄10.7[8.0 - 14.5]岁)和43名对照组儿童(26名女性,中位年龄12.7[9.2 - 18.2]岁)中,两组在年龄(P = 0.13)和性别(P = 0.50)上相匹配,SCD组的TIVLA中位数为35.9平方毫米[30.7, 39.5],大于对照组(30.5平方毫米[27.8, 35.4],P = 0.002)。在一个包含年龄、性别、血红蛋白、脑血流量、SCD状态以及血红蛋白与SCD状态之间相互作用的混合模型中,脑血流量(β = 0.11,可信区间0.02 - 0.20,P = 0.02)、SCD(β = 28.02,可信区间5.62 - 50.42,P = 0.015)以及SCD与血红蛋白之间的相互作用(β = -2.48,可信区间 - 4.49至 - 0.47,P = 0.018)均与TIVLA增加显著相关。值得注意的是,即使在混合模型中调整了脑血流量,作为动脉管腔测量指标的TIVLA在患有SCD的儿童中仍更大。这意味着可能需要特定疾病的标准值来检测早期血管病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/91f8d2f19a57/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/12baa128a17c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/cba60f09a321/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/00f71c720945/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/91f8d2f19a57/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/12baa128a17c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/cba60f09a321/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/00f71c720945/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4b7/12172934/91f8d2f19a57/gr3.jpg

相似文献

1
Cerebral arterial lumens are enlarged in children and young adults with sickle cell disease compared to peers.与同龄人相比,患有镰状细胞病的儿童和年轻人的脑动脉管腔会扩大。
Neuroimage Rep. 2025 Jun;5(2). doi: 10.1016/j.ynirp.2025.100265. Epub 2025 May 9.
2
Association of Cerebral Hemodynamics and Anemia on Processing Speed in Adults with Sickle Cell Disease.镰状细胞病成人患者脑血流动力学与贫血对处理速度的影响
J Neurol Exp Neural Sci. 2023;5(1). doi: 10.29011/2577-1442.100050. Epub 2023 Jul 24.
3
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
4
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.镰状细胞病患者无症状性脑梗死的预防干预措施。
Cochrane Database Syst Rev. 2017 May 13;5(5):CD012389. doi: 10.1002/14651858.CD012389.pub2.
5
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
6
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
7
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
8
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
9
The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.儿童镰状细胞病的一级卒中预防的临床效果和成本效益:系统评价和经济评估。
Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430.
10
Antioxidant supplementation for sickle cell disease.抗氧化剂补充治疗镰状细胞病。
Cochrane Database Syst Rev. 2024 May 22;5(5):CD013590. doi: 10.1002/14651858.CD013590.pub2.

本文引用的文献

1
Hemorrhagic Stroke in Children and Adults With Sickle Cell Anemia: The Post-STOP Cohort.镰状细胞贫血儿童和成人的出血性脑卒中:STOP 后队列。
Stroke. 2022 Nov;53(11):e463-e466. doi: 10.1161/STROKEAHA.122.038651. Epub 2022 Oct 7.
2
Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease.儿童镰状细胞病造血干细胞移植后脑血流动力学的正常化。
Blood. 2023 Jan 26;141(4):335-344. doi: 10.1182/blood.2022016618.
3
MR Imaging Differences in the Circle of Willis between Healthy Children and Adults.
Willis 环在健康儿童和成人的 MRI 影像中的差异。
AJNR Am J Neuroradiol. 2021 Nov;42(11):2062-2069. doi: 10.3174/ajnr.A7290. Epub 2021 Sep 23.
4
A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.横断面病例对照研究镰状细胞病患者颅内动脉壁厚度和全血细胞计数测量值。
Br J Haematol. 2021 Feb;192(4):769-777. doi: 10.1111/bjh.17262. Epub 2020 Dec 16.
5
Predicting Vessel Diameter Changes to Up-Regulate Biphasic Blood Flow During Activation in Realistic Microvascular Networks.预测真实微血管网络激活过程中血管直径变化以上调双相血流
Front Physiol. 2020 Oct 16;11:566303. doi: 10.3389/fphys.2020.566303. eCollection 2020.
6
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.美国血液学会2020年镰状细胞病指南:儿童和成人脑血管疾病的预防、诊断和治疗
Blood Adv. 2020 Apr 28;4(8):1554-1588. doi: 10.1182/bloodadvances.2019001142.
7
Carotid atherosclerosis, dilation, and stiffness relate to cerebral small vessel disease.颈动脉粥样硬化、扩张和僵硬与脑小血管疾病有关。
Neurology. 2020 Apr 28;94(17):e1811-e1819. doi: 10.1212/WNL.0000000000009319. Epub 2020 Apr 2.
8
Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (c-Jun N-Terminal Kinase).镰状细胞贫血介导颈动脉扩张性重塑,可通过抑制 JNK(c-Jun N 端激酶)来预防。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1220-1230. doi: 10.1161/ATVBAHA.120.314045. Epub 2020 Mar 12.
9
Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium.使用经颅多普勒超声预防镰状细胞贫血卒中的实践模式:DISPLACE 联盟。
Pediatr Blood Cancer. 2020 Apr;67(4):e28172. doi: 10.1002/pbc.28172. Epub 2020 Jan 11.
10
Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.镰状细胞病患儿缺血性中风生理学理解进展及血管病变的影响
Stroke. 2019 Feb;50(2):266-273. doi: 10.1161/STROKEAHA.118.020482.